US Stock MarketDetailed Quotes

FENC Fennec Pharmaceuticals

Watchlist
  • 9.230
  • +0.140+1.54%
Close May 3 16:00 ET
  • 9.230
  • 0.0000.00%
Post 16:02 ET
250.13MMarket Cap-15383P/E (TTM)

About Fennec Pharmaceuticals Company

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Company Profile

SymbolFENC
Company NameFennec Pharmaceuticals
Listing DateSep 13, 2017
Founded1996
CEOMr. Rostislav Raykov
MarketNASDAQ
Employees29
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressResearch Triangle Park,68 T.W. Alexander Drive
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27709
Phone1-919-636-4530
Websitehttp://www.fennecpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Rostislav Raykov
  • Director and Chief Executive Officer
  • 614.16K
  • Adrian J. Haigh
  • Chief Operating Officer
  • 106.95K
  • Robert Andrade
  • Chief Financial Officer and Principal Accounting Officer
  • 428.92K
  • Dr. Khalid Islam, PhD
  • Chairman of the Board
  • 168.69K
  • Chris A. Rallis
  • Independent Director
  • 109.45K
  • Dr. Marco M. Brughera
  • Independent Director
  • 106.95K
  • Dr. Jodi A. Cook, PhD
  • Independent Director
  • 101.95K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg